Authors:
Deininger, M
Ponisch, W
Krahl, R
Leiblein, S
Edel, E
Lange, T
Fiedler, F
Freund, M
Franke, A
Pasold, R
von Grunhagen, U
Herold, M
Dolken, G
Hoffmann, FA
Uhle, R
Schultze, W
Steglich, J
Schwarzer, A
Richter, P
Winkelmann, C
Kettner, E
Dachselt, K
Subert, R
Schwalbe, E
Doepper, J
Helbig, W
Niederwieser, D
Citation: M. Deininger et al., Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens, BONE MAR TR, 27(11), 2001, pp. 1125-1132
Authors:
Yasukawa, M
Bando, S
Dolken, G
Sada, E
Yakushijin, Y
Fujita, S
Makino, H
Citation: M. Yasukawa et al., Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals, BLOOD, 98(2), 2001, pp. 486-488
Authors:
Gahn, B
Brittinger, G
Dolken, G
Dohner, H
Emmerich, B
Franke, A
Freund, M
Huber, C
Kuse, R
Scholten, T
Hiddemann, W
Citation: B. Gahn et al., Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia, LEUK LYMPH, 37(1-2), 2000, pp. 169-173
Citation: C. Hirt et G. Dolken, Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation, BONE MAR TR, 25(4), 2000, pp. 419-426
Citation: L. Dolken et al., Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes, BIOTECHNIQU, 25(6), 1998, pp. 1058-1064
Authors:
Tesch, H
Diehl, V
Lathan, B
Hasenclever, D
Sieber, M
Ruffer, U
Engert, A
Franklin, J
Pfreundschuh, M
Schalk, KP
Schwieder, G
Wulf, G
Dolken, G
Worst, P
Koch, P
Schmitz, N
Bruntsch, U
Tirier, C
Muller, U
Loeffler, M
Citation: H. Tesch et al., Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: A study of the German Hodgkin's Lymphoma Study Group, BLOOD, 92(12), 1998, pp. 4560-4567